The START Center for Cancer Research has announced a strategic partnership with Advarra to accelerate and streamline ...

Macrophage checkpoint inhibitors promise a transformative role in cancer immunotherapy; by targeting the “don’t eat me” ...

The growing incidence of HPV16-positive cancers represents a significant challenge in oncology despite recent therapeutic advances. In this exclusive interview, Frank Bedu-Addo, President and CEO of ...

The V Foundation for Cancer Research has appointed Clark Kinlin as Interim CEO, following the departure of Shane Jacobson, who will assume the role of CEO at the American Cancer Society.

The American Cancer Society (ACS) and its advocacy arm, the American Cancer Society Cancer Action Network (ACS CAN), have appointed Shane Jacobson as their new Chief Executive Officer, effective ...

ONCOLife presents an exclusive interview with John Santini, CEO of Vergent Bioscience. In this session, we explore how intraoperative molecular imaging with abenacianine for injection (VGT-309) is ...

ONCOLife presents an exclusive interview with Dr. John Gribben, Professor at the Cancer Institute in London. In this session, ...

ONCOLife presents an exclusive interview with Lorna Warwick, CEO of Lymphoma Coalition. In this session, we explore the critical role of patient advocacy in improving access to CAR T-cell therapy — a ...

Today, we are hosting Dr. Raza Bokhari, CEO at Medicus Pharma, to explore a breakthrough innovation in skin cancer treatment—SkinJect, a novel microneedle patch designed to eradicate cancerous cells ...

The FDA has granted Breakthrough Device Designation to PreveCol, a blood test for early colorectal cancer detection developed by Amadix.